Sichenzia Ross Friedman Ference LLP Advises Underwriter Aegis Capital on U.S. Initial Public Offering of Israeli Biopharmaceutical Company

Represents first Israeli-American collaborative transaction between affiliated law firms SRFF LLP and DTKGC & Co.

New York, NY – May 15, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented the underwriter Aegis Capital Corp. on the U.S. initial public offering of BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV), an Israeli biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infection diseases. The public offering involved the sale of 1,910,000 American Depositary Shares (ADSs), with each ADS representing 40 of its ordinary shares, and warrants to purchase 1,910,000 ADSs (excluding over-allotment option) at an offering price of $5.00 per ADS and $0.01 per warrant. Biondvax raised approximately $9,550,000 in gross proceeds.

This is the first collaborative transaction completed between SRFF and its new affiliate Israeli law firm, Doron, Tikotzky, Kantor, Gutman, Cederboum & Co. (“DTKGC”). DTKGC’s partner Ronen Kantor led the Israeli team and represented Aegis Capital Corp. as the underwriter in Israel and SRFF’s partner Gregory Sichenzia and Associate Gary Emmanuel advised Aegis Capital Corp. as underwriter in the U.S.  SRFF and DTKGC launched an affiliate partnership earlier this month to provide their Israeli and American clients the ability to seamlessly conduct public offerings in the U.S. and Israeli capital markets.

• Author
• Recent Posts

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry.  In addition to handling routine to complex commercial matters, SRFC’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.  The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation.  Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies.  The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA).  These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct.  Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records.  The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRFC's LinkedIn page

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

• Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $8.5 Million Offering - September 13, 2024
• Sichenzia Ross Ference Carmel LLP Represents NuZee, Inc. in Two PIPE Transactions Totaling $4.3 Million - September 12, 2024

• Author
• Recent Posts

DTKGC -SRFF

DTKCG-SRFF is the international affiliation between New York-based securities and corporate law firm Sichenzia Ross Ference Kesner LLP (“SRFK”) and Israeli-based law firm Doron, Tikotzky, Kantor, Gutman, Cederboum and Co. The affiliation was established in 2015 to offer Israeli client companies opportunities to seamlessly gain access and raise capital in the U.S. markets.

Latest posts by DTKGC -SRFF (see all)